Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%

ClinicalTrials.gov ID: NCT00598832

Public ClinicalTrials.gov record NCT00598832. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 4:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Randomized, Double-Blind, Parallel Group Study to Demonstrate the Efficacy and Safety of Adapalene Lotion, 0.1% Compared With Vehicle Lotion in Subjects With Acne Vulgaris

Study identification

NCT ID
NCT00598832
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Galderma R&D
Industry
Enrollment
1,075 participants

Conditions and interventions

Conditions

Interventions

  • Adapalene lotion 0.1% Drug
  • Adapalene Lotion Vehicle Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2007
Primary completion
Sep 30, 2008
Completion
Oct 31, 2008
Last update posted
Feb 17, 2021

2007 – 2008

United States locations

U.S. sites
27
U.S. states
19
U.S. cities
27
Facility City State ZIP Site status
Burke Pharmaceutical Research Hot Springs Arkansas 71913
Scott Dinehart Little Rock Arkansas 72205
Dermatology and Laser Center Marina del Rey California 90292
Therapeutics Clinical Research San Diego California 92123
Solano Clinical Research Vallejo California 94589
Colorado Medical Research Center Denver Colorado 80210
Longmont Clinic Longmont Colorado 80501
Advanced Dermatology Clermont Florida 34711
International Dermatology Research, Inc. Miami Florida 33144
Anne M. Loebl Augusta Georgia 30904
Scott Glazer Buffalo Grove Illinois 60089
Sound Bend Clinic South Bend Indiana 46617
Hamzavi Dermatology Port Huron Michigan 48060
Central Dermatology, PC St Louis Missouri 63117
Darmouth-Hitchcock Medical Center Section of Dermatology Lebanon New Hampshire 03756
Academic Dermatology Albuquerque New Mexico 87106
Elizabeth Arthur Rochester New York 14609
Derm Research Center of New York Stony Brook New York 11790
Unifour Medical Research Associates Hickory North Carolina 28601
Haber Dermatology & Cosmetic Research South Euclid Ohio 44118
OU Health Sciences Center-Dept. of Dermatology Oklahoma City Oklahoma 73104
Oregon Medical Center, PC Portland Oregon 97223
Rivergate Dermatology Goodlettsville Tennessee 37072
DermResearch, Inc. Austin Texas 78759
Center for Clinical Studies Houston Texas 77058
Progressive Clinical Research San Antonio Texas 78229
Virginia Clinical Research, Inc. Norfolk Virginia 23507

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00598832, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 17, 2021 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00598832 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →